We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01078350
First Posted: March 2, 2010
Last Update Posted: November 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Stanford University
  Purpose
This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.

Condition Intervention
Lymphoma Hodgkin Disease Procedure: tumor tissue aspiration Procedure: phlebotomy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Further analysis [ Time Frame: at collection time ]

Biospecimen Retention:   Samples With DNA
tissues sample

Enrollment: 93
Actual Study Start Date: May 2004
Study Completion Date: December 4, 2015
Primary Completion Date: December 4, 2015 (Final data collection date for primary outcome measure)
Detailed Description:
The purpose of this study is to provide a mechanism to obtain tissue specimens to be used for experimental studies before the exact histologic diagnosis is known.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.
Criteria

Inclusion Criteria:

  • Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study.

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01078350


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Dr. Neyssa Marina Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01078350     History of Changes
Other Study ID Numbers: BANKPEDSTS0001
80003
SU-11052007-794 ( Other Identifier: Stanford )
First Submitted: February 26, 2010
First Posted: March 2, 2010
Last Update Posted: November 20, 2017
Last Verified: November 2017

Keywords provided by Stanford University:
Lymphoma
Hodgkin Disease

Additional relevant MeSH terms:
Hodgkin Disease
Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases